Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Cell Death & Disease|October 24, 2018
miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosisCuijuan Shi, Chun Rao, Cuiyun Sun, et al.Nucleic Acids Research|January 21, 2014
Transcriptome analysis of alternative splicing events regulated by SRSF10 reveals position-dependent splicing modulationXuexia Zhou, Wenwu Wu, Huang Li, et al.Oncotargets and Therapy|September 15, 2018
miR-361-5p inhibits glioma migration and invasion by targeting SND1Jing Liu, Jie Yang, Lin Yu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable PeptideDan Hua, Lida Tang, Weiting Wang, et al.The Journal of Clinical Investigation|November 28, 2018
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1BXuexia Zhou, Run Wang, Xuebing Li, et al.The American Journal of Pathology|October 13, 2018
miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' PrognosisWenjun Luo, Cuiyun Sun, Junhu Zhou, et al.British Journal of Cancer|August 9, 2017
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patientsCuijuan Shi, Linlin Ren, Cuiyun Sun, et al.Oncotarget|February 5, 2017
miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patientsHuining Li, Lin Yu, Jing Liu, et al.Neuroscience Letters|January 28, 2015
miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3BHui Xu, Jing Sun, Cuijuan Shi, et al.Journal of Translational Medicine|February 14, 2025
ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in gliomaYunlan Xi, Qingqing Yang, Yixuan Wang, et al.Pageof 4